These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28925507)

  • 1. (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells.
    Ying L; Yan F; Williams BR; Xu P; Li X; Zhao Y; Hu Y; Wang Y; Xu D; Dai J
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):58-67. PubMed ID: 28925507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells.
    Xiong X; Zhang J; Liang W; Cao W; Qin S; Dai L; Ye D; Liu Z
    Int J Oncol; 2016 Aug; 49(2):623-8. PubMed ID: 27278257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells.
    Xiong X; Zhang J; Li A; Dai L; Qin S; Wang P; Liu W; Zhang Z; Li X; Liu Z
    Cancer Biol Ther; 2020; 21(3):213-222. PubMed ID: 31651209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
    Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
    Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate inhibits the proliferation and induces apoptosis of multiple myeloma cells via inactivating EZH2.
    Zhou CG; Hui LM; Luo JM
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2093-2098. PubMed ID: 29687868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition.
    Amatangelo MD; Garipov A; Li H; Conejo-Garcia JR; Speicher DW; Zhang R
    Cell Cycle; 2013 Jul; 12(13):2113-9. PubMed ID: 23759589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer.
    Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism.
    Pereira ASA; Amaral MS; Vasconcelos EJR; Pires DS; Asif H; daSilva LF; Morales-Vicente DA; Carneiro VC; Angeli CB; Palmisano G; Fantappie MR; Pierce RJ; Setubal JC; Verjovski-Almeida S
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006873. PubMed ID: 30365505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
    Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
    Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
    Ihira K; Dong P; Xiong Y; Watari H; Konno Y; Hanley SJ; Noguchi M; Hirata N; Suizu F; Yamada T; Kudo M; Sakuragi N
    Oncotarget; 2017 Feb; 8(8):13509-13520. PubMed ID: 28088786
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Guo J; Zhu H; Li Q; Dong J; Xiong W; Yu K
    Aging (Albany NY); 2021 Apr; 13(8):11665-11677. PubMed ID: 33879635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
    Zhang CX; Wang SM; Jin HY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
    Wang Y; Jin HY; Fang MZ; Wang XF; Chen H; Huang SL; Kong DS; Li M; Zhang X; Sun Y; Wang SM
    World J Gastroenterol; 2020 May; 26(17):2064-2081. PubMed ID: 32536775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of histone methyltransferase inhibition in endometriosis.
    Colón-Caraballo M; Torres-Reverón A; Soto-Vargas JL; Young SL; Lessey B; Mendoza A; Urrutia R; Flores I
    Biol Reprod; 2018 Aug; 99(2):293-307. PubMed ID: 29408993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.
    He SB; Zhou H; Zhou J; Zhou GQ; Han T; Wan DW; Gu W; Gao L; Zhang Y; Xue XF; Zhang LF; Fei M; Hu SQ; Yang XD; Zhu XG; Wang L; Li DC
    Exp Biol Med (Maywood); 2015 Apr; 240(4):458-66. PubMed ID: 25005166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Histone Methyltransferase Inhibitors on the Survival, Apoptosis and Cell Cycle of Raji Cells].
    Xiao LR; Hou C; Zheng SJ; Guo B; Chen DN; Yan NH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):305-310. PubMed ID: 31631594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
    Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
    Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
    Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.
    Ding YP; Gao ZL; Chen BC; Rakariyatham K; Suo HY; Tong HR; Xiao H
    Nutr Cancer; 2018 Oct; 70(7):1126-1136. PubMed ID: 30513211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.